In this study, plumbagin could inhibit the levels of inflammatory cytokines and MMPs by inhibiting the activation of the NF-κB pathway, thereby attenuating RA-induced damage to cells and joints. This evidence concerns the gene NFKB1 and rheumatoid arthritis.